DiaSorin (OTCMKTS:DSRLF) Reaches New 52-Week Low – Should You Sell?
DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) shares hit a new 52-week low during trading on Monday . The company traded as low as $106.85 and last traded at $106.85, with a volume of 30 shares changing hands. The stock had previously closed at $107.17. Wall Street Analysts Forecast Growth Separately, UBS Group downgraded shares […]
More Stories
Surgery Partners (NASDAQ:SGRY) Research Coverage Started at Bank of America
Bank of America started coverage on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research report released on...
Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $63.00 by Analysts at Oppenheimer
Keros Therapeutics (NASDAQ:KROS – Free Report) had its price target trimmed by Oppenheimer from $102.00 to $63.00 in a report...
Digihost Technology’s (DGHI) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Digihost Technology (NASDAQ:DGHI – Free Report) in a research report sent...
a.k.a. Brands (NYSE:AKA) Earns Buy Rating from Analysts at Lake Street Capital
Lake Street Capital assumed coverage on shares of a.k.a. Brands (NYSE:AKA – Free Report) in a research note issued to...
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Recommendation of “Hold” from Brokerages
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has received a consensus rating of “Hold” from the eleven analysts that...
Occidental Petroleum Co. (NYSE:OXY) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Occidental Petroleum Co. (NYSE:OXY – Get Free Report) have been assigned an average rating of “Hold” from the...